US 7,598,276 B2Granted

Pharmaceutical salts and polymorphs of a factor Xa inhibitor

AssigneeMillenium Pharmaceuticals, Inc.

InventorsCraig Grant, James P. Kanter, Graeme Langlands

Life of this patent

Estimating the term…

Abstract

The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.

Claims5

Dependent claims

A salt represented by Formula II:

having a crystalline polymorph form.

Dependencies are inferred from the claim text.

Facts

Application: 11/594,280Filed 7 Nov 2006 · us provisional application
Priority: 8 Nov 2005
Published: US 2007/0112039 A117 May 2007
Granted: 6 Oct 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof
A61K 9/20
Medicinal preparations characterised by special physical form: pills, tablets, discs, rods
A61K 31/194
Carboxylic acids, e.g. valproic acid: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K 31/616
Having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid: by carboxylic acids, e.g. acetylsalicylic acid

Family

Application60/735,224Us provisional application · filed 8 Nov 2005
US 2007/0112039 A1Pre-grant publication · published 17 May 2007
US 7,598,276 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results